BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31263574)

  • 1. Platelet factor 4-containing immune complexes induce platelet activation followed by calpain-dependent platelet death.
    Nevzorova TA; Mordakhanova ER; Daminova AG; Ponomareva AA; Andrianova IA; Le Minh G; Rauova L; Litvinov RI; Weisel JW
    Cell Death Discov; 2019; 5():106. PubMed ID: 31263574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
    Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
    J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia.
    Cines DB; Yarovoi SV; Zaitsev SV; Lebedeva T; Rauova L; Poncz M; Arepally GM; Khandelwal S; Stepanova V; Rux AH; Cuker A; Guo C; Ocariza LM; Travers RJ; Smith SA; Kim H; Morrissey JH; Conway EM
    Blood Adv; 2016 Nov; 1(1):62-74. PubMed ID: 29296696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PF4-HIT antibody (KKO) complexes activate broad innate immune and inflammatory responses.
    Haile LA; Rao R; Polumuri SK; Arepally GM; Keire DA; Verthelyi D; Sommers CD
    Thromb Res; 2017 Nov; 159():39-47. PubMed ID: 28968537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?
    Sarkar A; Khandelwal S; Koma GT; Kim H; Gruel Y; Rollin J; Passam F; Wool GD; Arepally GM; Cines DB; Rauova L; Poncz M
    Blood Adv; 2023 Aug; 7(15):4112-4123. PubMed ID: 37196641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of fluid-phase immune complexes in the pathogenesis of heparin-induced thrombocytopenia.
    Huynh A; Arnold DM; Smith JW; Elliott TD; Ivetic N; Kelton JG; Nazy I
    Thromb Res; 2020 Oct; 194():135-141. PubMed ID: 32788105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies.
    Arepally GM; Kamei S; Park KS; Kamei K; Li ZQ; Liu W; Siegel DL; Kisiel W; Cines DB; Poncz M
    Blood; 2000 Mar; 95(5):1533-40. PubMed ID: 10688805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated platelets kill Staphylococcus aureus, but not Streptococcus pneumoniae-The role of FcγRIIa and platelet factor 4/heparinantibodies.
    Wolff M; Handtke S; Palankar R; Wesche J; Kohler TP; Kohler C; Gruel Y; Hammerschmidt S; Greinacher A
    J Thromb Haemost; 2020 Jun; 18(6):1459-1468. PubMed ID: 32237268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet Activation in Heparin-Induced Thrombocytopenia is Followed by Platelet Death via Complex Apoptotic and Non-Apoptotic Pathways.
    Mordakhanova ER; Nevzorova TA; Synbulatova GE; Rauova L; Weisel JW; Litvinov RI
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32272655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
    Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
    J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation.
    Johnston I; Sarkar A; Hayes V; Koma GT; Arepally GM; Chen J; Chung DW; López JA; Cines DB; Rauova L; Poncz M
    Blood; 2020 Apr; 135(15):1270-1280. PubMed ID: 32077913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.
    Litvinov RI; Yarovoi SV; Rauova L; Barsegov V; Sachais BS; Rux AH; Hinds JL; Arepally GM; Cines DB; Weisel JW
    J Biol Chem; 2013 Nov; 288(46):33060-70. PubMed ID: 24097975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of New Monoclonal PF4-Specific Antibodies as Useful Tools for Studies on Typical and Autoimmune Heparin-Induced Thrombocytopenia.
    Vayne C; Nguyen TH; Rollin J; Charuel N; Poupon A; Pouplard C; Normann N; Gruel Y; Greinacher A
    Thromb Haemost; 2021 Mar; 121(3):322-331. PubMed ID: 33086397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes.
    Krauel K; Fürll B; Warkentin TE; Weitschies W; Kohlmann T; Sheppard JI; Greinacher A
    J Thromb Haemost; 2008 Dec; 6(12):2160-7. PubMed ID: 18983520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody.
    Li ZQ; Liu W; Park KS; Sachais BS; Arepally GM; Cines DB; Poncz M
    Blood; 2002 Feb; 99(4):1230-6. PubMed ID: 11830470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation.
    Newman PM; Chong BH
    Blood; 2000 Jul; 96(1):182-7. PubMed ID: 10891449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
    Kizlik-Masson C; Deveuve Q; Zhou Y; Vayne C; Thibault G; McKenzie SE; Pouplard C; Loyau S; Gruel Y; Rollin J
    Blood; 2019 May; 133(22):2427-2435. PubMed ID: 30917957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review.
    Warkentin TE; Greinacher A
    Semin Thromb Hemost; 2023 Sep; 49(6):621-633. PubMed ID: 36455619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.
    Rauova L; Zhai L; Kowalska MA; Arepally GM; Cines DB; Poncz M
    Blood; 2006 Mar; 107(6):2346-53. PubMed ID: 16304054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomic description of the immune complex involved in heparin-induced thrombocytopenia.
    Cai Z; Yarovoi SV; Zhu Z; Rauova L; Hayes V; Lebedeva T; Liu Q; Poncz M; Arepally G; Cines DB; Greene MI
    Nat Commun; 2015 Sep; 6():8277. PubMed ID: 26391892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.